Research Grant
[Cite as http://purl.org/au-research/grants/nhmrc/1060538]Researchers: A/Pr Marc Ruitenberg (Principal investigator) , Dr Nyoman Kurniawan , Prof Stephen Taylor
Brief description This project will focus on the development of a new drug that is designed to attenuate the harmful inflammatory response that follows from spinal cord injury (SCI). The experiments will determine if the therapeutic targeting of an immune receptor molecule, called C5aR, can protect compromised neural tissues after injury against harmful inflammation and degeneration whilst also explore the mechanism behind the therapeutic effect.
Funding Amount $AUD 406,838.12
Funding Scheme Project Grants
Notes Standard Project Grant
- PURL : http://purl.org/au-research/grants/nhmrc/1060538
- nhmrc : 1060538